(Q43672714)

25 November 2017

title

Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders (English)

1 reference

25 November 2017

N Nikolettos

1

1 reference

25 November 2017

S Al-Hasani

2

1 reference

25 November 2017

R Felberbaum

3

1 reference

25 November 2017

L C Demirel

4

1 reference

25 November 2017

W Kupker

5

1 reference

25 November 2017

P Montzka

6

1 reference

25 November 2017

Y X Xia

7

1 reference

25 November 2017

B Schopper

8

1 reference

25 November 2017

R Sturm

9

1 reference

25 November 2017

K Diedrich

10

1 reference

25 November 2017

publication date

1 August 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

25 November 2017

published in

1 reference

25 November 2017

volume

97

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

202-207

1 reference

The importance of the follicular phase to success and failure in in vitro fertilization

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Hormonal responses to the new potent GnRH antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

High fertilization and implantation rates after intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Mini-swim-up: a new technique of sperm preparation for intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

A novel method of ovarian stimulation for in vitro fertilization: bromocriptine-rebound method.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

Intracytoplasmic sperm injection as a routine indication in low responder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

A new indication for an intracytoplasmic sperm injection procedure outside the cases of severe male factor infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900535-2

7 January 2021

10.1016/S0301-2115(00)00535-2

Identifiers

DOI

1 reference

25 November 2017

1 reference